Fresenius Medical Care is set to buy NxStage Medical for about $2 billion. The takeover will bolster Fresenius’ presence in the at-home dialysis market, positioning it to continue profiting if ...
Please provide your email address to receive an email when new articles are posted on . Those who own stock in dialysis machine maker NxStage Medical Inc. will have an opportunity on Oct. 27 to weigh ...
Here are six stocks that fell to 52-week lows: While trading on above-average volume, NxStage Medical (NASDAQ:NXTM) slipped today, hitting and then dropping past its previous 52-week low to $13.62.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback